Japan Questions Reliability of Vasculitis Drug Approval Data
Tokyo, Oct. 21 (Jiji Press)--Japan's health ministry said Wednesday that there may be problems with the reliability of documents submitted by Kissei Pharmaceutical Co. for the approval of vasculitis drug Tavneos. In its response to a series of deaths among Tavneos users, the ministry reiterated its request that medical institutions refrain from starting new patients on the drug, which is ma...